| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
12,843 |
11,006 |
$415K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,277 |
2,897 |
$203K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,593 |
2,408 |
$135K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
2,348 |
2,148 |
$116K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,737 |
1,557 |
$73K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
925 |
840 |
$42K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
362 |
310 |
$33K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
338 |
292 |
$30K |
| 90686 |
|
2,070 |
1,873 |
$23K |
| 90670 |
|
1,515 |
1,431 |
$16K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,515 |
728 |
$16K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,100 |
781 |
$14K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
308 |
265 |
$10K |
| 90698 |
|
842 |
797 |
$10K |
| 90680 |
|
897 |
838 |
$9K |
| 87634 |
|
123 |
112 |
$9K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
567 |
505 |
$6K |
| 99460 |
|
43 |
43 |
$4K |
| 99173 |
|
341 |
310 |
$4K |
| 90633 |
|
362 |
323 |
$4K |
| 90697 |
|
296 |
271 |
$4K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
48 |
48 |
$3K |
| 90656 |
|
203 |
193 |
$2K |
| 90677 |
|
207 |
196 |
$2K |
| 90744 |
|
203 |
188 |
$2K |
| 99188 |
|
90 |
80 |
$2K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
1,192 |
1,094 |
$1K |
| 83655 |
|
102 |
84 |
$1K |
| 81002 |
|
369 |
311 |
$1K |
| 96127 |
|
437 |
403 |
$907.45 |
| 90685 |
|
88 |
86 |
$822.16 |
| 87807 |
|
64 |
58 |
$741.57 |
| 85018 |
|
248 |
221 |
$647.54 |
| 99381 |
|
15 |
13 |
$549.09 |
| 90710 |
|
44 |
41 |
$513.77 |
| 90696 |
|
41 |
40 |
$500.63 |
| 90707 |
|
31 |
27 |
$328.50 |
| 90716 |
|
30 |
26 |
$315.36 |
| 90700 |
|
29 |
26 |
$302.22 |
| 92552 |
|
15 |
15 |
$277.20 |
| D1206 |
Topical application of fluoride varnish |
13 |
12 |
$219.40 |
| 90648 |
|
15 |
14 |
$200.85 |
| 90651 |
|
13 |
12 |
$170.48 |
| 90619 |
|
14 |
13 |
$150.94 |
| 94760 |
|
16 |
14 |
$57.20 |
| 91307 |
|
16 |
14 |
$0.12 |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
213 |
210 |
$0.00 |
| 96160 |
|
2,444 |
2,257 |
$0.00 |
| 99072 |
|
267 |
221 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
37 |
35 |
$0.00 |